Metronidazole Norma

Metronidazole, the active ingredient in Metronidazole Norma, is a nitroimidazole presented as an injection for intravenous use. It is employed to treat anaerobic bacterial infections and certain protozoal diseases, such as bacterial vaginosis, trichomoniasis, amebic liver abscess and Clostridioides difficile infection, in both adult and pediatric patients as determined by a prescriber.

GNH USA supplies Metronidazole Norma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and logistics for global healthcare providers.

Metronidazole is indicated for several anaerobic and protozoal infections, acting on organisms that thrive in low‑oxygen environments.

- Anaerobic bacterial infections: effective in treating intra‑abdominal, pelvic, skin and soft‑tissue infections caused by susceptible anaerobes. - Bacterial vaginosis: restores normal vaginal flora by eliminating Gardnerella and other anaerobes. - Trichomoniasis: eradicates Trichomonas vaginalis in genital infections. - Amebic liver abscess: resolves hepatic lesions caused by Entamoeba histolytica. - Clostridioides difficile infection: reduces toxin‑producing C. difficile in selected cases.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools, usually self‑limiting. - Headache: mild headache. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Seizures: rare neurologic events, especially with high doses. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reaction: anaphylaxis, swelling, difficulty breathing. - Hepatotoxicity: elevated liver enzymes or jaundice.

When using Metronidazole, clinicians should observe several precautions to minimize risks.

- Assess renal and hepatic function: adjust therapy in patients with impairment. - Avoid alcohol: concurrent intake can cause a disulfiram‑like reaction. - Monitor for neurotoxicity: watch for seizures or peripheral neuropathy during prolonged therapy. - Use caution in pregnancy: safety category is unknown; weigh benefits against potential risks. - Evaluate for hypersensitivity: discontinue if rash or anaphylaxis occurs. - Store at room temperature: keep below 25 °C, protect from moisture and light in original packaging.

Metronidazole can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, nausea. - Warfarin: increased anticoagulant effect, risk of bleeding. - Lithium: elevated lithium levels, potential toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Phenobarbital: may reduce metronidazole levels, decreasing effectiveness. - Oral contraceptives: possible reduction in contraceptive efficacy; advise additional protection.